Grant: Project Grant
University of Toronto
$344,251.00
Patient Engagement Partnerships in Clinical Trials (PEP-CT): Systematic Development and Testing of Patient Partner and Investigator Decision Aids
FY 2019-20
Summary
The overall goal of this 2-year project is to build capacity for sex/gender uptake and patient engagement in clinical trials. A clinical trial is a research study used to compare a new drug to a harmless pill, or placebo. In Canada, we are changing our approach to clinical trial research. We now believe that patients (men and women) should be partners in deciding on the importance of research, designing studies, and sharing study results. However, investigators do not know how to work with patients, and patients do not know how to work with investigators. Our work will refine and test two decision aids to build capacity for sex/gender uptake and patient engagement in clinical trials. Decision aids can assist patients
and investigators weigh their own potential benefits/risks of engaging patients as partners in clinical trial research. We have completed Phase 1 (CIHR-funded) of this project. We partnered with Clinical Trials Ontario and collaborated with patients, investigators, health care providers, and health charity and patient organizations to design two decision aids: one for patients and one for investigators. We are now seeking further funding to refine, translate (English to French), and test the decision aids through: 1) alpha (usability) testing (Phase 2), and 2) beta (field) testing (Phase 3). These methods follow International Patient Decision Aid Standards. In Phase 2, we will conduct testing cycles of five patients (men and women) and five investigators (men and women) per testing cycle. After each cycle we will make changes and continue testing cycles until no further comments are received. In Phase 3, we will test each decision aid with English- and French-speaking patients and investigators to ensure
they are: 1) clear, 2) acceptable, and 3) easy to use. We have a strong project team that includes patient partners, investigators, and Clinical Trials Ontario who will make the decision aids freely available on their website.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
418604
Name
Parry Monica J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Clinical
Prcname2
Knowledge Mobilization Science
Projecttitle
Patient Engagement Partnerships in Clinical Trials (PEP-CT): Systematic Development and Testing of Patient Partner and Investigator Decision Aids
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$344,251
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Clinical Trial; Decision Aid; Patient Partner; Patient-Oriented Research; Sex/Gender
Abstract
The overall goal of this 2-year project is to build capacity for sex/gender uptake and patient engagement in clinical trials. A clinical trial is a research study used to compare a new drug to a harmless pill, or placebo. In Canada, we are changing our approach to clinical trial research. We now believe that patients (men and women) should be partners in deciding on the importance of research, designing studies, and sharing study results. However, investigators do not know how to work with patients, and patients do not know how to work with investigators. Our work will refine and test two decision aids to build capacity for sex/gender uptake and patient engagement in clinical trials. Decision aids can assist patients
and investigators weigh their own potential benefits/risks of engaging patients as partners in clinical trial research. We have completed Phase 1 (CIHR-funded) of this project. We partnered with Clinical Trials Ontario and collaborated with patients, investigators, health care providers, and health charity and patient organizations to design two decision aids: one for patients and one for investigators. We are now seeking further funding to refine, translate (English to French), and test the decision aids through: 1) alpha (usability) testing (Phase 2), and 2) beta (field) testing (Phase 3). These methods follow International Patient Decision Aid Standards. In Phase 2, we will conduct testing cycles of five patients (men and women) and five investigators (men and women) per testing cycle. After each cycle we will make changes and continue testing cycles until no further comments are received. In Phase 3, we will test each decision aid with English- and French-speaking patients and investigators to ensure
they are: 1) clear, 2) acceptable, and 3) easy to use. We have a strong project team that includes patient partners, investigators, and Clinical Trials Ontario who will make the decision aids freely available on their website.
Competitiondate
202003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Parry, Monica J; Ceroni, Tina
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $344,251~ $0~